2 GHP / Q2 2019 Editor’s Note , Welcome to the Q2 issue of Global Health & Pharma Magazine - your source for the latest news and features from across the healthcare and pharmaceutical industries. The global healthcare industry is diverse, expansive and, always, innovative: moving forwards, improving and evolving to tackle the challenges of the sector. So, this quarter, we have chosen to highlight some of these exemplars to see how they pursue perfection, whatever that may mean in their market. From ground-breaking dentistry to a world-leading communications agency, healthcare encompasses many things indeed, and all play a crucial role in the day to day operations of the industry. First up, we spoke with Paul Hagopian, Co-Founder and Head of Client Partnerships of SPLICE Agency, a healthcare advertising agency in Emeryville, California. Following their recognition as the ‘Best Healthcare Communications Agency’ in GHP’s Private Healthcare Awards, we were eager to find out more about this essential area of the healthcare industry. Later in the issue, we spotlight the American Association of Pharmaceutical Scientists (AAPS) to find out how they are supporting their members in all stages of the drug development process through a focus on science, careers and ‘community’. Walter Marlowe, Executive Director at AAPS, was eager to tell us more. Here at GHP Magazine, we hope that you enjoy reading this quarter’s issue and look forward to hearing from you soon. With kind regards, Laura Brookes, Editor Phone: +44 (0) 203 970 0082 Email: l.brooke [email protected] Website: www.ghp-news.com AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.